Lung resident type 2 innate lymphoid cells (ILC2) have been shown to function as a potential early source for IL-5 and IL-13, and are supposed to contribute to allergen-independent AHR and asthma (Kim et al., 2012). The gene discussed is IL13; the disease is asthma.